Finance

Beta
Lists
4569:TYO
Kyorin Pharmaceutical Co Ltd
1 178,00 JPY
+1,03%
(+12,00) 1D
3 ივლ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4569...
Open
1 171 JPY
High
1 197 JPY
Low
1 170 JPY
Mkt. cap
70,62 მლრდ.
Avg. vol.
250,90 ათ.
Volume
150,00 ათ.
Dividend
4,84%
Quarterly dividend
14 JPY
Ex-dividend date
30 მარ. 2026
P/E ratio
19,63
52-wk high
1 725 JPY
52-wk low
1 067 JPY
EPS
60 JPY
Shares outstanding
63,52 მლნ.
No. of employees
2 ათ.
Open
1 171 JPY
High
1 197 JPY
Low
1 170 JPY
Mkt. cap
70,62 მლრდ.
Avg. vol.
250,90 ათ.
Volume
150,00 ათ.
Dividend
4,84%
Quarterly dividend
14 JPY
Ex-dividend date
30 მარ. 2026
P/E ratio
19,63
52-wk high
1 725 JPY
52-wk low
1 067 JPY
EPS
60 JPY
Shares outstanding
63,52 მლნ.
No. of employees
2 ათ.
News stories
From sources across the web
About Kyorin Pharmaceutical Co Ltd
CEO-
Employees1,98 ათ.
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitekyorin-pharm.co.jp
Last report
12 მაი. 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
33,80 მლრდ. / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
30,23 მლრდ.
28,50 მლრდ.
33,72 მლრდ.
33,80 მლრდ.
Cost of goods sold
16,97 მლრდ.
16,87 მლრდ.
19,09 მლრდ.
21,71 მლრდ.
Cost of revenue
16,97 მლრდ.
16,87 მლრდ.
19,09 მლრდ.
21,71 მლრდ.
Research and development expenses
-
-
-
12,06 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,89 მლრდ.
12,64 მლრდ.
11,39 მლრდ.
1,07 მლრდ.
Operating expense
10,89 მლრდ.
12,69 მლრდ.
11,39 მლრდ.
13,13 მლრდ.
Total operating expenses
27,86 მლრდ.
29,56 მლრდ.
30,48 მლრდ.
34,84 მლრდ.
Operating income
2,37 მლრდ.
-1,06 მლრდ.
3,24 მლრდ.
-1,04 მლრდ.
Other non operating income
15,00 მლნ.
11,00 მლნ.
12,00 მლნ.
13,00 მლნ.
EBT including unusual items
2,73 მლრდ.
-699,00 მლნ.
3,49 მლრდ.
-1,07 მლრდ.
EBT excluding unusual items
2,62 მლრდ.
-1,04 მლრდ.
3,51 მლრდ.
-1,07 მლრდ.
Income tax expense
628,00 მლნ.
-93,00 მლნ.
869,00 მლნ.
-402,00 მლნ.
Effective tax rate
23,02%
13,30%
24,87%
37,47%
Other operating expenses
-
-
-
-
Net income
2,10 მლრდ.
-606,00 მლნ.
2,62 მლრდ.
-671,00 მლნ.
Net profit margin
6,95%
-2,13%
7,78%
-1,99%
Earnings per share
-
-
-
-
Interest and investment income
233,00 მლნ.
38,00 მლნ.
235,00 მლნ.
12,00 მლნ.
Interest expense
-64,00 მლნ.
-61,00 მლნ.
-59,00 მლნ.
-70,00 მლნ.
Net interest expenses
169,00 მლნ.
-23,00 მლნ.
176,00 მლნ.
-58,00 მლნ.
Depreciation and amortization charges
2,00 მლნ.
3,00 მლნ.
3,00 მლნ.
2,00 მლნ.
EBITDA
3,52 მლრდ.
82,00 მლნ.
4,39 მლრდ.
121,75 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer